Drug dosing in acute renal failures: The role of renal replacement therapy in altering drug pharmacokinetics

Advances in Renal Replacement Therapy

Volumn 5, Issue 2, 1998, Pages 141-147

  Subach, R A ^a   Marx, M A ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Critical care; Drug therapy; Kidney failure, acute; Pharmacokinetics; Renal replacement therapy

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPICILLIN; AMRINONE; ANTIINFECTIVE AGENT; CEFOPERAZONE; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; DIAZEPAM; DIGOXIN; ERYTHROMYCIN; FAMOTIDINE; FLUCONAZOLE; GENTAMICIN; LIDOCAINE; METRONIDAZOLE; NAFCILLIN; PHENYTOIN; PIPERACILLIN; PROCAINAMIDE; RANITIDINE; SULFAMETHOXAZOLE; TOBRAMYCIN; VANCOMYCIN;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; DOSE CALCULATION; DRUG MONITORING; ELECTROLYTE BALANCE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY TRANSPLANTATION; PATHOPHYSIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

EID: 0031895749     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1073-4449(98)70008-1     Document Type: Article

References (18)

1. Chertow GM Owen WF Jr Lazarus JM Conventional hemodialysis for acute renal failure Bellomo R Ronco C Acute Renal Failure in the Critically Ill Update in Intensive Care and Emergency Medicine 20 1995 265 297
2. Mehta RL Continuous renal replacement therapies in the acute renal failure setting: Current concepts Adv Ren Replace Ther 4 suppl 1 1997 81 92
3. Golper TA Continuous arteriovenous hemofiltration in acute renal failure Am J Kidney Dis 6 1985 373 386
4. Rumpf KW Rieger J Doht B Ansorg R Scheler F Drug elimination by hemofiltration J Dial 1 1977 677 678
5. Kronfol NO Lau AH Barakat MM Aminoglycoside binding to polyacrylonitrile hemofilter membranes during continuous hemofiltration ASAIO Trans 33 1987 300 303
6. Cigarran-Guldris S Brier ME Golper TA Tobramycin clearance during simulated continuous arteriovenous hemodialysis Contrib Nephrol 93 1991 120 123
7. Henderson LW Colton CK Ford CA Kinetics of hemodiafiltration. II: Clinical characterization of a new blood cleansing modality J Lab Clin Med 85 1975 372 391
8. Levy G Pharmacokinetics in renal disease Am J Med 62 1977 461 463
9. Reeves JH Butt WW A comparison of solute clearance during continuous hemofiltration, hemodiafiltration, and hemodialysis using a polysulfone hemofilter ASAIO J 41 1995 100 104
10. Golper TA Wedel SK Kaplan AA Saad AM Donta ST Paganini EP Drug removal during continuous arteriovenous hemofiltration: Theory and clinical observations Int J Artif Organs 8 1985 307 312
11. Kroh UF Dehne M el Abed K Feussner KD Hofmann W Lennartz H Drug dosage during continuous hemofiltration: Pharmacokinetics and practical implications Contrib Nephrol 93 1991 127 130
12. Golper TA Marx MA Shuler C Bennett WM Drug Dosage in Dialysis Patients Jacobs C Kjellstrand CM Koch KM Winchester JF Replacement of Renal Function by Dialysis 1996 Kluwer Academic Publishers Dordrecht, The Netherlands
13. Dasta JF Armstrong DK Variability in aminoglycoside pharmacokinetics in critically ill surgical patients Crit Care Med 16 1988 327 330
14. Bauer LA Rebound gentamicin levels after hemodialysis Ther Drug Monit 4 1982 99 101
15. Matzke GR O'Connell MB Collins AJ Keshaviah PR Disposition of vancomycin during hemofiltration Clin Pharmacol Ther 40 1986 425 430
16. Golper TA, Marx MA: Removal of drugs, toxins and poisons by continuous hemofiltration, in Ronco C. Bellomo R (eds): Critical Care Nephrology. The Netherlands Kluwer Academic Publishers (in press)
17. Bennett WM Aronoff GR Morrison G Golper TA Brater DC Singer I Drug prescribing in renal failure: Dosing guidelines for adults 1994 American College of Physicians Philadelphia, PA
18. Davies SP Kox WJ Brown EA Clearance studies in patients with acute renal failure treated by continuous arteriovenous hemodialysis Contrib Nephrol 93 1991 117 119